17 Recruiting Lung Cancer Clinical Trials in California
Explore active lung cancer research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Lung Cancer Studies in California
Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
📍 UCSD Moores Cancer Center — La Jolla, California
View Study & Checklist ➔To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
📍 Research Site — La Jolla, California
View Study & Checklist ➔A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
📍 Providence Medical Foundation ( Site 0117) — Fullerton, California
View Study & Checklist ➔Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
📍 Scripps Memorial Hospital — Encinitas, California
View Study & Checklist ➔Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer
📍 Hoag Memorial Hospital Presbyterian — Newport Beach, California
View Study & Checklist ➔A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
📍 California Cancer Associates for Research and Excellence, Inc. (cCare) — Encinitas, California
View Study & Checklist ➔Enhancing Lung Cancer Screening Through Human-Centered Intervention
📍 University of California, Davis — Sacramento, California
View Study & Checklist ➔Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
📍 City of Hope Cancer Center — Duarte, California
View Study & Checklist ➔Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
📍 Stanford University — Stanford, California
View Study & Checklist ➔Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
📍 University of California Los Angeles — Los Angeles, California
View Study & Checklist ➔Next Generation Chest X-Ray Tomosynthesis for Screening of Lung Cancer
📍 University of California San Diego — San Diego, California
View Study & Checklist ➔Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
📍 University of California Davis Cancer Center — Sacramento, California
View Study & Checklist ➔Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
📍 The University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
📍 Stanford University — Palo Alto, California
View Study & Checklist ➔Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔Empathic Communication Skills (ECS) Training
📍 Providence St. Joseph Health (Data Collection Only) — Irvine, California
View Study & Checklist ➔Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
📍 Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
View Study & Checklist ➔